Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Monogram Biosciences collaborates with Merck on phase III trials of MK-0518

Feb. 27, 2006

Fast track designation for viral entry inhibitor PRO-140

Feb. 23, 2006

Geron's small-molecule telomerase activators show utility for HIV/AIDS

Feb. 23, 2006

Recent Roche patent reports novel therapeutics for HIV infection

Feb. 22, 2006

Targeted CCR5 gene disruption renders human primary cells resistant to HIV

Feb. 22, 2006

New HIV protease inhibitor shows promise for multidrug-resistant HIV infection

Feb. 21, 2006

CD38-derived peptide shows potent anti-HIV-1 activity in vitro

Feb. 21, 2006

Preclinical and clinical data on JTK-303/GS-9137 disclosed

Feb. 21, 2006

Orally available novel nucleotide is active against drug-resistant HIV-1 mutants

Feb. 21, 2006

Kureha presents data on its new chemokine CXCR4 antagonists

Feb. 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...